Below are the most recent publications written about "Neoplasm Invasiveness" by people in Profiles.
-
Chan PS, Patel AJ, Lucchese G, Bille A. Multimodal management and complete resection of invasive Type B3 thymoma with vascular reconstruction: a case report. J Cardiothorac Surg. 2025 Jan 07; 20(1):40.
-
Geynisman DM, Abbosh PH, Ross E, Zibelman MR, Ghatalia P, Anari F, Mark JR, Stamatakis L, Hoffman-Censits JH, Viterbo R, Greenberg RE, Churilla TM, Horwitz EM, Hallman MA, Smaldone MC, Uzzo R, Chen DYT, Kutikov A, Plimack ER. Phase II Trial of Risk-Enabled Therapy After Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer (RETAIN 1). J Clin Oncol. 2025 03 20; 43(9):1113-1122.
-
Whitehorn GL, Rshaidat H, Madeka I, Martin J, Mack SJ, Meredith L, Alaparthi S, Grenda TR, Evans NR, Okusanya OT. Lobectomy Is Not Associated With Improved Survival as Compared to Segmentectomy in Early-Stage Lung Cancer Patients With Visceral Pleural Invasion. Clin Lung Cancer. 2025 Mar; 26(2):e99-e107.e10.
-
Kaliki S, Vempuluru VS, Bakal KR, Dorji S, Tanna V, Shields CN, Fallon SJ, Raval V, Ahmad A, Mushtaq A, Hussain M, Yousef YA, Mohammad M, Roy SR, Huque F, Tatiana U, Yuri S, Vladimir P, Zambrano SC, Alarc?n-Le?n S, Valdiviezo-Zapata C, Vargas-Martorellet M, Gutierrez-Chira C, Buitrago M, Ortiz JS, Diaz-Coronado R, Tripathy D, Rath S, Patil G, Berry JL, Pike S, Brown B, Tanabe M, Frenkel S, Eiger-Moscovich M, Pe'er J, Shields CL, Eagle RC, Laiton A, Velasco AM, Vega K, DeSimone J, Bejjanki KM, Kapoor AG, Venkataraman A, Bryant V, Reddy MA, Sagoo MS, Hubbard GB, Azarcon CP, Olson TA, Grossniklaus H, Rolfe O, Staffieri SE, O'Day R, Mathew AA, Elder JE, McKenzie JD, Fabian ID, Shemesh R, Vishnevskia-Dai V, Ali MH, Jakati S, Mishra DK, Palkonda VAR. HIGH-RISK HISTOPATHOLOGICAL FEATURES OF RETINOBLASTOMA FOLLOWING PRIMARY ENUCLEATION: A Global Study Of 1,426 Patients From 5 Continents. Retina. 2024 12 01; 44(12):2105-2115.
-
Arazi M, Baum A, Casavilca-Zambrano S, Alarcon-Leon S, Diaz-Coronado R, Ahmad A, Mushtaq A, Hussain M, Ushakova T, Yuri S, Vladimir P, Shields CL, Eagle RC, Berry JL, Pike S, Brown B, Roy SR, Huque F, Fabian I, Frenkel S, Eiger-Moscovich M, Pe'er J, Hubbard GB, Olson TA, Grossniklaus H, Reddy MA, Sagoo MS, Staffieri SE, Elder JE, McKenzie JD, Tanabe M, Kaliki S, Fabian ID. Treatment Outcomes and Definition Inconsistencies in High-Risk Unilateral Retinoblastoma. Am J Ophthalmol. 2024 Dec; 268:399-408.
-
Dogan E, Galifi CA, Cecen B, Shukla R, Wood TL, Miri AK. Extracellular matrix regulation of cell spheroid invasion in a 3D bioprinted solid tumor-on-a-chip. Acta Biomater. 2024 09 15; 186:156-166.
-
Abou Chakra M, Shore ND, Brown ES, Du GJ, O'Donnell MA. Establishing an Intravesical Doublet Chemotherapy Clinic for Nonmuscle-Invasive Bladder Cancer Patients. Urol Pract. 2024 07; 11(4):613-623.
-
Necchi A, Roumigui? M, Kamat AM, Shore ND, Boormans JL, Esen AA, Lebret T, Kandori S, Bajorin DF, Krieger LEM, Niglio SA, Uchio EM, Seo HK, de Wit R, Singer EA, Grivas P, Nishiyama H, Li H, Baranwal P, Van den Sigtenhorst-Fijlstra M, Kapadia E, Kulkarni GS. Pembrolizumab monotherapy for high-risk non-muscle-invasive bladder cancer without carcinoma in situ and unresponsive to BCG (KEYNOTE-057): a single-arm, multicentre, phase 2 trial. Lancet Oncol. 2024 06; 25(6):720-730.
-
Narayan VM, Boorjian SA, Alemozaffar M, Konety BR, Shore ND, Gomella LG, Kamat AM, Bivalacqua TJ, Montgomery JS, Lerner SP, Busby JE, Poch M, Crispen PL, Steinberg GD, Schuckman AK, Downs TM, Mashni J, Lane BR, Guzzo TJ, Bratslavsky G, Karsh LI, Woods ME, Brown G, Canter D, Luchey A, Lotan Y, Inman BA, Williams MB, Cookson MS, Chang SS, Sankin AI, O'Donnell MA, Sawutz D, Philipson R, Parker NR, Yla-Herttuala S, Rehm D, Jakobsen JS, Juul K, Dinney CPN. Efficacy of Intravesical Nadofaragene Firadenovec for Patients With Bacillus Calmette-Gu?rin-Unresponsive Nonmuscle-Invasive Bladder Cancer: 5-Year Follow-Up From a Phase 3 Trial. J Urol. 2024 07; 212(1):74-86.
-
Moussa M, Abou Chakra M, Shore ND, Papatsoris A, Farahat Y, O'Donnell MA. Patterns of treatment of high-risk BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) patients among Arab urologists. Arch Ital Urol Androl. 2024 Mar 19; 96(1):12244.